Page 122 - 南京医科大学学报自然科学版
P. 122
第43卷第9期
·1300 · 南 京 医 科 大 学 学 报 2023年9月
18
[31] HACKER C D,PERLMUTTER J S,CRISWELL S R,et 步采集 F⁃FDG 显像与 ASL 脑血流灌注成像相关性及
al. Resting state functional connectivity of the striatum in 鉴别诊断价值[J]. 中华核医学与分子影像杂志,2019,
Parkinson’s disease[J]. Brain,2012,135(12):3699- 38(6):337-343
3711 [41] XUAN M,GUAN X,HUANG P,et al. Different patterns
[32] MILLER⁃THOMAS M M,BENZINGER T L. Neurologic of gray matter density in early⁃ and middle⁃late⁃onset Par⁃
applications of PET/MR imaging[J]. Magn Reson Imag⁃ kinson’s disease:a voxel⁃based morphometry study[J].
ing Clin N Am,2017,25(2):297-313 Brain Imaging Behav,2019,13(1):172-179
[33] MORADI F,IAGARU A,MCCONATHY J. Clinical appli⁃ [42] CHOI H,CHEON G J,KIM H J,et al. Gray matter corre⁃
cations of PET/MR imaging[J]. Radiol Clin North Am, lates of dopaminergic degeneration in Parkinson’s dis⁃
2021,59(5):853-874 ease:a hybrid PET/MR study using(18)F⁃FP⁃CIT[J].
[34] AIELLO M,CAVALIERE C,MARCHITELLI R,et al. Hy⁃ Hum Brain Mapp,2016,37(5):1710-1721
brid PET/MRI methodology[J]. Int Rev Neurobiol,2018, [43] KALIA L V,LANG A E. Parkinson’s disease[J]. Lancet,
141:97-128 2015,386(9996):896-912
[35] CATANA C. Principles of simultaneous PET/MR imaging [44] OBESO I,CASABONA E,RODRIGUEZ⁃ROJAS R,et al.
[J]. Magn Reson Imaging Clin N Am,2017,25(2):231- Unilateral subthalamotomy in Parkinson’s disease:cogni⁃
243 tive,psychiatric and neuroimaging changes[J]. Cortex,
[36] DRZEZGA A,BARTHEL H,MINOSHIMA S,et al. Poten⁃ 2017,94:39-48
tial clinical applications of PET/MR imaging in neurode⁃ [45] RODRIGUEZ⁃ROJAS R,PINEDA⁃PARDO J A,MARTI⁃
generative diseases[J]. J Nucl Med,2014,55(S2):47- NEZ⁃FERNANDEZ R,et al. Functional impact of subthal⁃
55 amotomy by magnetic resonance ⁃ guided focused ultra⁃
[37] PORTER E,ROUSSAKIS A A,LAO ⁃ KAIM N P,et al. sound in Parkinson’s disease:a hybrid PET/MR study of
Multimodal dopamine transporter(DAT)imaging and mag⁃ resting⁃state brain metabolism[J]. Eur J Nucl Med Mol
netic resonance imaging(MRI)to characterise early Par⁃ Imaging,2020,47(2):425-436
kinson’s disease[J]. Parkinsonism Relat Disord,2020, [46] DUAN C L,SU Y,ZHAO C L,et al. The assays of activi⁃
79:26-33 ties and function of TH,AADC,and GCH1 and their
[38] LEVIN J,KURZ A,ARZBERGER T,et al. The differen⁃ potential use in ex vivo gene therapy of PD[J]. Brain Res
tial diagnosis and treatment of atypical Parkinsonism[J]. Brain Res Protoc,2005,16(1⁃3):37-43
Dtsch Arztebl Int,2016,113(5):61-69 [47] SEO Y,HAWKINS R,CHRISTINE C. In vivo quantitative
[39] BARTHEL H,SCHROETER M L,HOFFMANN K T,et PET/MR imaging of gene expression in Parkinson ’s
al. PET/MR in dementia and other neurodegenerative dis⁃ Disease[J]. J Nucl Med,2015,56(S3):417
eases[J]. Semin Nucl Med,2015,45(3):224-233 [收稿日期] 2023-05-15
[40] 孙 逊,刘 芳,阮伟伟,等. 帕金森综合征PET/MR 同 (本文编辑:陈汐敏)